R. Michael Giuffre
Independent DirectorDr. R. Michael Giuffre, BSc, MD, MBA, FRCP, FACC has been Independent Director of DiaMedica Therapeutics Inc. (formerly known as DiaMedica Inc.) since August 2010. He served as a Consultant for Redsky Inc. As a Biotechnology Consultant, Dr. Giuffre is involved with MDMI and MedMira Inc. He served as Secretary of IC2E International Inc., prior to merger with IC2E, Inc. since July 19, 2007. He served as a Director of Vacci-Test Corporation, FoodChek Systems Inc. and IC2E International Inc. He serves on the Board of Directors for UNICEF Canada. He served as a Director of MedMira Inc., since January 31, 2001. He served as a Director of Can-Cal Resources Ltd. from October 24, 2012 to March 2013. He serves as the President of the Alberta Medical Association. Dr. Giuffre was President of the Calgary and Area Physicians Association (CAPA). He is also an MD-MP contact for the Canadian Medical Association. He serves on the Medical Advisory Board of the SADS Foundation He serves on the Board of Directors of the Alberta Medical Association. Dr. Giuffre previously served on the Board of Directors of the Canadian Medical Association (CMA), UnicefCanada, Can-Cal Resources Ltd, MedMira Incorporated and Brightsquid Dental, Incorporated. From 2012 to October 2019, Dr. Giuffre served as Chief Scientific Officer and President of FoodChek Laboratory. From November 2017 to October 2019, he served as FoodChek Systems Inc. Chairman of the Board. Dr. Giuffre is currently a Member of the Board of Directors of Avenue Living (AL) Asset Management. AL Real Estate Opportunity Trust and AgriSelect Trust. He is a volunteer on the Patrons' Council for UNICEF Alberta. He was a Representative to the Board of the Calgary Health Region. He has been a Clinical Professor of Cardiac Sciences and Pediatrics in the Faculty of Medicine at the University of Calgary since July 2009. In 2005, he was awarded Physician of the Year by the Calgary Medical Society. He is a recipient of a Certified and Registered appointment by the American Academy of Cardiology, as Distinguished Fellow of the American Academy of Cardiology. In 2017 was "Mentor of the Year" for the Royal College of Physicians and Surgeons of Canada. He is Canadian Royal College Board certified FRCPS in specialties that include Pediatrics and Pediatric Cardiology and has a subspecialty in Pediatric Cardiac Electrophysiology. His Canadian Royal College Board certified specialties include Pediatrics, Pediatric Cardiology and a subspecialty in Pediatric Electrophysiology. Dr. Giuffre holds a BSc in Cellular and Microbial Biology, a PhD candidacy in Molecular Virology and an MD. Dr. Giuffre holds an Executive MBA Program from the University of Calgary/University of Alberta in 2001.
Positions
- Company NameDiaMedica Therapeutics Inc.Stock CodeDMACPositionIndependent DirectorColleagues
- DJDietrich John PaulsPresident, CEO & Director
- JTJames T. ParsonsIndependent Chairman
- SKScott KellenCFO & Corporate Secretary
- JKJulie KropChief Medical Officer
- ASAmbarish ShahChief Technology Officer
- DRDominic R. CundariChief Commercial Officer
- DJDaniel J. O'ConnorIndependent Director
- PBPhilip BathMember of Stroke Advisory Board
